What is a decentralized clinical trial?

Article By Samantha Trolli IN Clinical Trials - 15th April, 2022

Image Description
Clinical trials have always been known to be executed in medical facilities. When the Covid-19 pandemic struck in 2020, much devastation occurred. The pandemic put a pause on many operations, including clinical trials. Clinical researchers needed to find a way to continue. This was done so by implementing a new upcoming way of research, decentralized clinical trials; Decentralized clinical trials are also referred to as DCT’s. The purpose of a DCT is to remove in-person contact between the study team and the patients/subjects. 
The benefits of DCT’s, are as listed:
  • Eliminating travel costs, distance, and extreme weather.
  • Avoiding absences of work for the participants/subjects.
  • Removing mobility challenges for the participants/subjects.
  • Increasing the demographic of participants/subjects.

One can see why the pandemic gave rise to a personalized and convenient form of research. Infiuss is joining the research revolution by utilizing the internet's ability to remove these obstacles to clinical trials (check out our blog: What Are The Benefits Of A Remote Platform For Clinical Trials?) Our goal is to promote the creation of DCT’s by providing a platform that allows access to create and participate in DCT’s. 

Expand your research bandwidth with Infiuss

Input your email to request a demo and we’ll get back to you promptly.

We care about your data, find out more in our privacy policy

We care about your data, find out more in our privacy policy